Averna Therapeutics Inc. — Form D/A

Averna Therapeutics Inc. of WATERTOWN, MA, a company, filed a Form D amendment with the SEC on 2026-03-20. The offering totals $85.0M, of which $85.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Thomas BarnesDirectorWatertown, MA
Nick OlsenDirectorWatertown, MA
Raju PrasadDirectorWatertown, MA
Michal SilverbergDirectorWatertown, MA
Tal ZaksDirectorWatertown, MA
Thomas BarnesExecutive OfficerWatertown, MA
Richard MorrisExecutive OfficerWatertown, MA
Tal ZaksExecutive OfficerWatertown, MA
Roy AmariglioRelated PersonWatertown, MA
Thomas BarnesRelated PersonWatertown, MA
Henry ChenRelated PersonBEDFORD, MA
Richard MorrisRelated PersonWatertown, MA
DYLAN MORRISRelated PersonWatertown, MA
Nick OlsenRelated PersonWatertown, MA
Raju PrasadRelated PersonWatertown, MA
Michal SilverbergRelated PersonWatertown, MA
Stephen SquintoRelated PersonStamford, CT
Tal ZaksRelated PersonWatertown, MA
Henry ChenDirectorBEDFORD, MA
Stephen SquintoDirectorStamford, CT
DYLAN MORRISDirectorWatertown, MA
Roy AmariglioDirectorWatertown, MA
Roy AmariglioExecutive OfficerWatertown, MA
Tal Zaks, M.D., Ph.D.DirectorWatertown, MA
Tal Zaks, M.D., Ph.D.Executive OfficerWatertown, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2025-04-21D/A$85.0M$43.8M
2024-04-17D$85.0M$38.8M

More